FM
CDMO

Fondren Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Fondren Management’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-205,000
Closed -$644K – 59
2017
Q3 		$644K Buy
+205,000
New +$770K 0.52% 35
2017
Q1 		– Sell
-642,857
Closed -$1.39M – 50
2016
Q4 		$1.39M Buy
+642,857
New +$1.5M 0.99% 25

Other funds holding CDMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BP
Bandera Partners New York $221M AUM 10.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Fondren Management's CDMO Position: Q4 2017 in Review

Fondren Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2017, closing a stake of 205,000 shares — an estimated $644K sold.

Fondren Management first reported a position in CDMO in Q4 2016 and held it in 2 quarters. The position peaked at $1.39M in Q4 2016. 56 funds tracked by Wall St. Rank hold CDMO as of Q4 2017.

  • Fondren Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Fondren Management sold 205,000 Avid Bioservices, Inc. Common Stock shares in Q4 2017, an estimated $644K.
  • Fondren Management first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2016 and held it in 2 quarters.
  • Fondren Management's Avid Bioservices, Inc. Common Stock position peaked at $1.39M in Q4 2016.
  • 56 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2017.

Based on Fondren Management's 13F filing for Q4 2017, filed 14 Feb 2018.